Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP261792.RAs21ot1mfIqXSpon0nhXW4BBXVIfapFw1RRPRvw6CTPQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP261792.RAs21ot1mfIqXSpon0nhXW4BBXVIfapFw1RRPRvw6CTPQ130_assertion type Assertion NP261792.RAs21ot1mfIqXSpon0nhXW4BBXVIfapFw1RRPRvw6CTPQ130_head.
- NP261792.RAs21ot1mfIqXSpon0nhXW4BBXVIfapFw1RRPRvw6CTPQ130_assertion description "[In conclusion, the Bcl-2 inhibitor ABT-737 sensitized cancer cells to the antitumor effect of antigen-specific immunotherapy in a vaccine model for the CT26 colon carcinoma in vivo but not in two immunotherapy strategies against B16 melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261792.RAs21ot1mfIqXSpon0nhXW4BBXVIfapFw1RRPRvw6CTPQ130_provenance.
- NP261792.RAs21ot1mfIqXSpon0nhXW4BBXVIfapFw1RRPRvw6CTPQ130_assertion evidence source_evidence_literature NP261792.RAs21ot1mfIqXSpon0nhXW4BBXVIfapFw1RRPRvw6CTPQ130_provenance.
- NP261792.RAs21ot1mfIqXSpon0nhXW4BBXVIfapFw1RRPRvw6CTPQ130_assertion SIO_000772 18807035 NP261792.RAs21ot1mfIqXSpon0nhXW4BBXVIfapFw1RRPRvw6CTPQ130_provenance.
- NP261792.RAs21ot1mfIqXSpon0nhXW4BBXVIfapFw1RRPRvw6CTPQ130_assertion wasDerivedFrom befree-20150227 NP261792.RAs21ot1mfIqXSpon0nhXW4BBXVIfapFw1RRPRvw6CTPQ130_provenance.
- NP261792.RAs21ot1mfIqXSpon0nhXW4BBXVIfapFw1RRPRvw6CTPQ130_assertion wasGeneratedBy ECO_0000203 NP261792.RAs21ot1mfIqXSpon0nhXW4BBXVIfapFw1RRPRvw6CTPQ130_provenance.